Thioridazine
Back to searchMolecule Structure
Scientific Name
Thioridazine
Description of the Drug
Thioridazine is a phenothiazine antipsychotic used to treat schizophrenia and generalized anxiety disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00679
http://www.drugbank.ca/drugs/DB00679
Brand Name(s)
Mellaril, Mellaril-s, Melleril, Rideril
Company Owner(s)
Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Actavis Mid Atlantic Llc, Mylan Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Akorn Operating Co Llc, Fosun Pharma Usa Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Ani Pharmaceuticals Inc, Wockhardt Eu Operations (Swiss) Ag
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
| Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
Clinical Trial(s)
Unichem Links
| Atlas | thioridazine | |
| SureChEMBL | SCHEMBL9566 | |
| PharmGKB | PA451666 | |
| Human Metabolome Database | HMDB0014817 | |
| DrugBank | DB00679 | |
| PubChem: Thomson Pharma | 14804036 | |
| PubChem | 5452 | |
| Mcule | MCULE-7796139302 | |
| LINCS | LSM-1863 | |
| Nikkaji | J4.104A | |
| BindingDB | 50002338 | |
| EPA CompTox Dashboard | DTXSID6023656 | |
| DrugCentral | 2637 | |
| Brenda | 6096 | |
| ChemicalBook | CB6763367 | |
| Guide to Pharmacology | 100 | |
| rxnorm | THIORIDAZINE HYDROCHLORIDE | THIORIDAZINE |
| PubChem: Drugs of the Future | 12013415 | |
| ChEBI | 9566 |
